REE Automotive Announces a Supplement to its Proxy Statement for its Special General Meeting of Shareholders to be held on November 13, 2025

Stock Information for Mersana Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Mersana Therapeutics Inc.

REE Automotive and Mitsubishi Fuso Truck and Bus Corporation Sign MOU for Software-Defined Vehicle Technology
REE Automotive Receives Nasdaq Minimum Bid Price Notification
REE Announces Cost Reduction Measures to Sustain Long-Term Growth
REE Automotive Announces Fourth Quarter and Fiscal Year 2024 Earnings Results
REE Automotive Provides 2024 Business Update; Reschedules Date for its Fourth-Quarter and Fiscal Year 2024 Earnings Results
REE Automotive Awarded Frost & Sullivan's 2025 Company of the Year in the North American Electric Medium-Duty Vehicle Platform Industry
REE Automotive to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on April 29, 2025
REE Automotive Announces Increase in Previously Announced Registered Direct Offering to $36.4 Million with Pricing of Additional $9.4 Million at Premium to Market, Led by Strategic Investor Motherson Group

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.